Skip to content
Open access · CC-BY via OpenAlex

Urolithin A Modulates SIRT ‐1 Mediated Improvement of Mitochondrial Health in Experimental Model of Oxaliplatin Induced Peripheral Neuropathy

Anubroto Pal, Sayani Banerjee, Lokesh Sharan, Ravindra Kumar, Neelanjan Chowdhury, Arka Das, Sarath Babu V, David Paul, Sugato Banerjee

Phytotherapy Research · 2026

Abstract

Oxaliplatin-induced peripheral neuropathy (OIPN) is a major dose-limiting adverse reaction of chemotherapy. It is characterised by motor and sensory hypersensitivity, loss of myelinated nerve fibres, oxidative stress, mitochondrial dysfunction(definition) and neuroinflammation. Urolithin A, a bioactive gut metabolite of ellagitannins, is recognised for its ability to restore mitochondrial homeostasis. This study investigated the neuroprotective efficacy of urolithin A against experimental OIPN, focusing on its ability to simultaneously balance mitochondrial biogenesis and mitophagy. To study OIPN, male Sprague-Dawley rats were administered oxaliplatin (4 mg/kg) over a 4-week period, paired with concurrent oral doses of urolithin A (25 and 50 mg/kg). The animals were evaluated through behavioural assays (Von Frey, Hargreaves Plantar and Randall-Selitto, etc.) and functional tests measuring sensory and motor nerve conduction velocity. Oxidative stress markers (MDA and GSH) and mitochondrial dynamics, specifically biogenesis and mitophagy, were measured. In parallel, an in vitro study exposed Neuro2a cells to 50 μM of oxaliplatin, followed by urolithin A treatment (15 μM), to investigate its neuroprotective efficacy and underlying molecular mechanisms. Urolithin A significantly attenuated OIPN, alleviating thermal and mechanical hypersensitivity in behavioural assessments. It mitigated oxidative stress and mitochondrial dysfunction while promoting mitochondrial biogenesis via the SIRT1-mediated pathway both in vitro and in vivo. Simultaneously, urolithin A enhanced mitophagy by directly activating SIRT1-induced autophagy(definition) markers, leading to a marked reduction in inflammatory cytokine levels and eventual mitigation of neuropathic pain. Urolithin A protected against oxaliplatin-induced neurotoxicity in Neuro2a cells and reversed peripheral neuropathy in rats by restoring SIRT1-mediated mitochondrial biogenesis and mitophagy balance and maintaining mitochondrial health. These findings highlight urolithin A as a potential therapeutic candidate for OIPN.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1002/ptr.70506
Canonical
link ↗
Fetched
2026-11-16 MST

Cite this

APA
Pal, A., Banerjee, S., Sharan, L., Kumar, R., Chowdhury, N., Das, A., V, S.B., Paul, D., &amp; Banerjee, S. (2026). Urolithin A Modulates SIRT ‐1 Mediated Improvement of Mitochondrial Health in Experimental Model of Oxaliplatin Induced Peripheral Neuropathy. <em>Phytotherapy Research</em>. https://doi.org/10.1002/ptr.70506
Vancouver
Pal A, Banerjee S, Sharan L, Kumar R, Chowdhury N, Das A, et al. Urolithin A Modulates SIRT ‐1 Mediated Improvement of Mitochondrial Health in Experimental Model of Oxaliplatin Induced Peripheral Neuropathy. Phytotherapy Research. 2026. doi:10.1002/ptr.70506.
BibTeX
@article{anubroto2026Urolit, title = {Urolithin A Modulates SIRT ‐1 Mediated Improvement of Mitochondrial Health in Experimental Model of Oxaliplatin Induced Peripheral Neuropathy}, author = {Anubroto Pal and Sayani Banerjee and Lokesh Sharan and Ravindra Kumar and Neelanjan Chowdhury and Arka Das and Sarath Babu V and David Paul and Sugato Banerjee}, journal = {Phytotherapy Research}, year = {2026}, doi = {10.1002/ptr.70506}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings